drugset / Trial / NCT00104169

Idiopathic Anemia of Aging (IAA)

NCT00104169 ↗

Non-randomizedTreatment

Summary

The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.

Timeline

Start
2004-08
Primary completion
2007-05
Completion
2007-05

Outcome

Outcome not reported

Stopped (Enrollment): “No subject accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic — —

Indications